Fusion Antibodies plc (AIM:FAB)
10.00
+1.25 (14.29%)
Jul 28, 2025, 4:26 PM GMT+1
Fusion Antibodies Employees
Fusion Antibodies had 27 employees as of March 31, 2024. The number of employees decreased by 21 or -43.75% compared to the previous year.
Employees
27
Change (1Y)
-21
Growth (1Y)
-43.75%
Revenue / Employee
66.74K GBP
Profits / Employee
-58.93K GBP
Market Cap
9.94M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 27 | -21 | -43.75% |
Mar 31, 2023 | 48 | -7 | -12.73% |
Mar 31, 2022 | 55 | 0 | - |
Mar 31, 2021 | 55 | 11 | 25.00% |
Mar 31, 2020 | 44 | 9 | 25.71% |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,382 |